Remedesivir Archives

Celebrating 20 Years of IP Excellence

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

In this week’s Patent News – CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug – Remdesivir; EPO creates search strategies to aid scientists distinguish documents relevant to fight the COVID-19 pandemic; EUIPO and EPO to jointly host online conference on Additive Manufacturing INDIA PATENT NEWS UPDATE CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug - Remdesivir The Communist Party of India (Marxist) has reportedly requested the Central…

July 13, 2020 BananaIP Reporter Intellectual Property, Patents 0Comment 730Views 0Like

ShareFacebook

Compulsory Licensing in India – Talk by Gaurav Mishra

Mr. Gaurav Mishra, Managing Associate at BananaIP Counsels delivered a talk on the Compulsory licensing provisions in India under the Patents Act on the 3rd of June 2020 at an event organized by the Department of Science and technology, Rajasthan. The webinar event was attended by over a 100 participants including, students, lawyers, medical professionals and academicians. The talk was delivered as part of the Rajasthan, DST's laudable initiative of creating IP awareness as well as helping the attendees grasp…

June 3, 2020 BananaIP Reporter Intellectual Property, Patents 0Comment 1192Views 0Like

ShareFacebook

Celebrating 20 Years of IP Excellence

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

Compulsory Licensing in India – Talk by Gaurav Mishra

Connect with Us

BananaIP has been acknowledged as a women-owned enterprise, certified by WEConnect International.

Connect with us